365 related articles for article (PubMed ID: 16682023)
1. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
[TBL] [Abstract][Full Text] [Related]
2. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
[TBL] [Abstract][Full Text] [Related]
3. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
[TBL] [Abstract][Full Text] [Related]
4. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of cyclase- versus non-cyclase-coupled D1-like dopamine receptors in orofacial movement topography in mice: studies with SKF 83822.
Makihara Y; Okuda Y; Kawada C; Matsumoto M; Waddington JL; Koshikawa N; Tomiyama K
Neurosci Lett; 2007 Mar; 415(1):6-10. PubMed ID: 17234342
[TBL] [Abstract][Full Text] [Related]
6. SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
Adachi K; Ikeda H; Hasegawa M; Nakamura S; Waddington JL; Koshikawa N
Eur J Pharmacol; 1999 Feb; 367(2-3):143-9. PubMed ID: 10078986
[TBL] [Abstract][Full Text] [Related]
7. Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D(1)-like vs. D(2)-like receptor regulation.
Tomiyama K; McNamara FN; Clifford JJ; Kinsella A; Koshikawa N; Waddington JL
Eur J Pharmacol; 2001 Apr; 418(1-2):47-54. PubMed ID: 11334864
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
Ryman-Rasmussen JP; Nichols DE; Mailman RB
Mol Pharmacol; 2005 Oct; 68(4):1039-48. PubMed ID: 15985612
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
Deveney AM; Waddington JL
Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
Desai RI; Terry P; Katz JL
Pharmacol Biochem Behav; 2005 Aug; 81(4):843-8. PubMed ID: 16000217
[TBL] [Abstract][Full Text] [Related]
11. Assessment of jaw movements by magnetic sensor in relation to topographies of orofacial behaviour in freely moving rats: Studies with the dopamine D(1)-like receptor agonists SKF 83822 vs SKF 83959.
Fujita S; Kiguchi M; Kobayashi M; Kinsella A; Koshikawa N; Waddington JL
Eur J Pharmacol; 2010 Apr; 632(1-3):39-44. PubMed ID: 20122923
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
13. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
14. Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK&F 82958 as an anomalous agent.
Makihara Y; Yamamoto H; Inoue M; Tomiyama K; Koshikawa N; Waddington JL
J Psychopharmacol; 2004 Dec; 18(4):484-95. PubMed ID: 15585467
[TBL] [Abstract][Full Text] [Related]
15. Comparative phenotypic resolution of spontaneous, D2-like and D1-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D2 vs. D3 receptor "knockout".
Tomiyama K; McNamara FN; Clifford JJ; Kinsella A; Drago J; Fuchs S; Grandy DK; Low MJ; Rubinstein M; Tighe O; Croke DT; Koshikawa N; Waddington JL
Synapse; 2004 Jan; 51(1):71-81. PubMed ID: 14579426
[TBL] [Abstract][Full Text] [Related]
16. Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.
O'Sullivan GJ; Kinsella A; Sibley DR; Tighe O; Croke DT; Waddington JL
Synapse; 2005 Mar; 55(4):201-11. PubMed ID: 15668951
[TBL] [Abstract][Full Text] [Related]
17. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
18. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
19. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of orofacial movement topography in mutants with disruption of amino acid mechanisms: glutamate N2A/B/D [GluRĪµ1/2/4] subtypes and the GABA synthesizing enzyme GAD65.
Tomiyama K; Kato R; Hara Y; Kobayashi M; Mishina M; Yanagawa Y; Kinsella A; Koshikawa N; Waddington JL
Neuroscience; 2013 Oct; 250():743-54. PubMed ID: 23892010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
